BusinessBiodesix Announces Biomarker Research Collaboration with Checkmate PharmaceuticalsBy Nasdaq OMXMar 20, 2018, 1:01 PM UTC
BusinessBiodesix Oral Presentation At SITC: Testing Methodology May Identify Primary Immunotherapy Resistance In PatientsBy Nasdaq OMXNov 7, 2017, 5:22 PM UTC
BusinessBiodesix Blood-Based Diagnostic Testing Approach To PD-L1 Detection Shows Concordance with ImmunohistochemistryBy Nasdaq OMXNov 1, 2017, 4:12 PM UTC
